Lemaitre Dan
Director at GMED; Director at ENDOLOGIX INC /DE/
- Sold, on record
- $8.8M
- Dollars the filings state
- Form 4 sales
- 6
- Latest Nov 22, 2024
- Form 144 notices
- 4
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- GMEDGLOBUS MEDICAL INCDirector
- ENDOLOGIX INC /DE/Director
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- GMED136,509 shares
- ENDOLOGIX INC /DE/54,097 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale GMEDUnusualMar 9, 2021 2021
Sold 15,384 shares at $62.47 ($961k)
Lemaitre Dan, Director
Sold 100% of holdings ($961k position)0 shares leftFirst sale on recordFiling
- 2 Form 144 notice GMEDNoticeMay 15, 2023 +797 days
Filed to sell 43,450 shares ($2.5M)
Lemaitre Dan, Director
No 10b5-1 planFirst sale on recordFiling
- 3 Form 4 sale GMEDUnusualMay 15, 2023 same day
Sold 43,450 shares at $56.98 ($2.5M)
Lemaitre Dan, Director
No 10b5-1 planSold 80.1% of holdings ($3.1M position)10,800 shares leftFirst sale on recordFollows a Form 144Filing
- 4 Form 144 notice GMEDNoticeMay 10, 2024 +361 days
Filed to sell 10,800 shares ($694k)
Lemaitre Dan, Director
No 10b5-1 planFiling
- 5 Form 144 notice GMEDNoticeMay 10, 2024 same day
Filed to sell 52,500 shares ($3.4M)
Lemaitre Dan, Director
No 10b5-1 planFiling
- 6 Form 4 sale GMEDUnusualMay 10, 2024 same day
Sold 63,300 shares at $64.61 ($4.1M)
Lemaitre Dan, Director
No 10b5-1 planSold 100% of holdings ($4.1M position)0 shares leftFollows a Form 144Filing
- 7 Form 144 notice GMEDNoticeNov 21, 2024 +195 days
Filed to sell 14,375 shares ($1.2M)
Lemaitre Dan, Director
No 10b5-1 planFirst sale on recordFiling
- 8 Form 4 sale GMEDUnusualNov 22, 2024 +1 day
Sold 14,375 shares at $85.00 ($1.2M)
Lemaitre Dan, Director
No 10b5-1 planSold 100% of holdings ($1.2M position)0 shares leftFirst sale on recordFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (10)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 22, 2024 | Nov 25, 2024 | GMED | Director | Form 4 sale | 14,375 | $1.2M | 100.0% | Unusual | SEC |
| Nov 21, 2024 | Nov 21, 2024 | GMED | Director | Form 144 notice | 14,375 | $1.2M | Notice | SEC | |
| May 10, 2024 | May 14, 2024 | GMED | Director | Form 4 sale | 63,300 | $4.1M | 100.0% | Unusual | SEC |
| May 10, 2024 | May 10, 2024 | GMED | Director | Form 144 notice | 52,500 | $3.4M | Notice | SEC | |
| May 10, 2024 | May 10, 2024 | GMED | Director | Form 144 notice | 10,800 | $694k | Notice | SEC | |
| May 15, 2023 | May 17, 2023 | GMED | Director | Form 4 sale | 43,450 | $2.5M | 80.1% | Unusual | SEC |
| May 15, 2023 | May 16, 2023 | GMED | Director | Form 144 notice | 43,450 | $2.5M | Notice | SEC | |
| Mar 9, 2021 | Mar 11, 2021 | GMED | Director | Form 4 sale | 15,384 | $961k | 100.0% | Unusual | SEC |
| Sep 4, 2020 | Sep 17, 2020 | ENDOLOGIX INC /DE/ | Director | Form 4 sale | 51,844 | $3k | 100.0% | Unusual | SEC |
| Aug 14, 2020 | Aug 19, 2020 | ENDOLOGIX INC /DE/ | Director | Form 4 sale | 2,253 | $192 | 4.2% | Plan not stated | SEC |